{"id":139687,"date":"2025-10-23T03:56:27","date_gmt":"2025-10-23T03:56:27","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/139687\/"},"modified":"2025-10-23T03:56:27","modified_gmt":"2025-10-23T03:56:27","slug":"unmet-healthcare-demand-in-asia-presents-chinese-hospital-operators-with-opportunities","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/139687\/","title":{"rendered":"Unmet healthcare demand in Asia presents Chinese hospital operators with opportunities"},"content":{"rendered":"<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">Driven by accelerating healthcare demand, Fosun Health plans to target markets in South Asia, Southeast Asia and the Middle East to capitalise on their economic growth and fragmented health systems, according to chairman and CEO Frank Hu Hang.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">The subsidiary of Hong Kong-listed Shanghai Fosun Pharmaceutical (Group) operates 19 hospitals, clinics and third-party diagnostics centres in mainland China. Four of these are in Foshan, Guangzhou, Shenzhen and Zhuhai \u2013 cities that are part of the Greater Bay Area that includes Hong Kong, Macau, Dongguan, Huizhou, Jiangmen, Zhaoqing and Zhongshan.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">\u201cWe genuinely see that there is significant unmet demand in the international medical markets in the post-Covid-19 era,\u201d Hu said in an interview. \u201cOur goal is to position ourselves as a viable solution for patients whose needs cannot be fully met locally.\u201d<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">While medical tourism is currently concentrated in Singapore and Thailand, Fosun wants to corner a share of the market, attracting overseas patients to China, especially to the Greater Bay Area.<\/p>\n<p><img decoding=\"async\" alt=\"Fosun Health is a subsidiary of Hong Kong-listed Shanghai Fosun Pharmaceutical. Photo: Handout\" data-qa=\"BaseImage-handleRenderImage-StyledImage\" class=\"e1gf69pb2 css-6ikqhs e445x7d0\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/10\/05c5ae97-345e-4c15-9a7f-39ab35217c73_b91830d1.jpg\" title=\"Fosun Health is a subsidiary of Hong Kong-listed Shanghai Fosun Pharmaceutical. Photo: Handout\"\/>Fosun Health is a subsidiary of Hong Kong-listed Shanghai Fosun Pharmaceutical. Photo: Handout<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">Hu said Indonesia faced a shortage of health professionals, with just 0.6 doctors for every 1,000 people. According to a 2024 report from PwC, this ratio ranged between 2.4 and 3.8 in the mainland\u2019s nine Greater Bay Area cities.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">\u201cWe are actively promoting Fosun\u2019s medical standards overseas to demonstrate our superior treatment capabilities,\u201d said Hu.<\/p>\n","protected":false},"excerpt":{"rendered":"Driven by accelerating healthcare demand, Fosun Health plans to target markets in South Asia, Southeast Asia and the&hellip;\n","protected":false},"author":2,"featured_media":139688,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[4692,22081,381,10503,18,4686,82731,82733,82734,43554,135,475,474,4202,19,7088,17,8820,82730,82732,4434],"class_list":{"0":"post-139687","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-bangladesh","9":"tag-belt-and-road-initiative","10":"tag-china","11":"tag-covid","12":"tag-eire","13":"tag-foshan","14":"tag-fosun-health","15":"tag-frank-hu-hang","16":"tag-greater-bay-area-gba","17":"tag-guangzhou","18":"tag-health","19":"tag-health-care","20":"tag-healthcare","21":"tag-hong-kong","22":"tag-ie","23":"tag-indonesia","24":"tag-ireland","25":"tag-middle-east","26":"tag-shanghai-fosun-pharmaceutical-group","27":"tag-south-asia","28":"tag-southeast-asia"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115421471260658471","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/139687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=139687"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/139687\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/139688"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=139687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=139687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=139687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}